Inger Helene Madshus

5.3k total citations · 2 hit papers
67 papers, 4.3k citations indexed

About

Inger Helene Madshus is a scholar working on Molecular Biology, Immunology and Cell Biology. According to data from OpenAlex, Inger Helene Madshus has authored 67 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 24 papers in Immunology and 23 papers in Cell Biology. Recurrent topics in Inger Helene Madshus's work include Toxin Mechanisms and Immunotoxins (23 papers), Cellular transport and secretion (22 papers) and Monoclonal and Polyclonal Antibodies Research (20 papers). Inger Helene Madshus is often cited by papers focused on Toxin Mechanisms and Immunotoxins (23 papers), Cellular transport and secretion (22 papers) and Monoclonal and Polyclonal Antibodies Research (20 papers). Inger Helene Madshus collaborates with scholars based in Norway, United States and Denmark. Inger Helene Madshus's co-authors include Espen Stang, Sjur Olsnes, Kirsten Sandvig, Harald Stenmark, Lene E. Johannessen, Camilla Raiborg, Kristi G. Bache, David J. Gillooly, Nina Marie Pedersen and Pål Ø. Falnes and has published in prestigious journals such as Cell, Journal of Biological Chemistry and The Journal of Cell Biology.

In The Last Decade

Inger Helene Madshus

67 papers receiving 4.2k citations

Hit Papers

2 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hrs sorts ubiquitinated proteins into clathrin-coated microdomains of early endosomes

2002 585 citations Camilla Raiborg, Inger Helene Madshus et al. profile →
Regulation of intracellular pH in eukaryotic cells

1988 505 citations Inger Helene Madshus Biochemical Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Inger Helene Madshus Norway	34	2.8k	1.4k	845	729	574	67	4.3k
Stephen Bottomley Australia	42	3.1k 1.1×	829 0.6×	447 0.5×	792 1.1×	376 0.7×	139	5.3k
Peter G.W. Gettins United States	43	3.2k 1.1×	1.4k 1.0×	713 0.8×	807 1.1×	269 0.5×	167	7.3k
Yoav I. Henis Israel	49	5.3k 1.9×	1.7k 1.2×	862 1.0×	468 0.6×	292 0.5×	159	7.3k
Melvyn Little Germany	44	3.2k 1.2×	1.1k 0.8×	803 1.0×	794 1.1×	2.1k 3.7×	131	5.1k
Cheri S. Lazar United States	26	2.9k 1.1×	858 0.6×	1.6k 1.9×	394 0.5×	1.0k 1.8×	31	4.6k
Martin Spiess Switzerland	43	4.0k 1.4×	1.8k 1.2×	406 0.5×	562 0.8×	332 0.6×	111	5.7k
Doron C. Greenbaum United States	36	3.4k 1.2×	633 0.4×	1.6k 1.9×	648 0.9×	265 0.5×	44	6.3k
Shoko Nishihara Japan	35	2.8k 1.0×	598 0.4×	330 0.4×	990 1.4×	385 0.7×	136	3.8k
Gerald Gish Canada	42	5.4k 1.9×	1.5k 1.1×	1.4k 1.7×	1.2k 1.6×	628 1.1×	77	7.8k
Ruibao Ren United States	38	4.5k 1.6×	719 0.5×	1.2k 1.4×	953 1.3×	353 0.6×	92	7.5k

Countries citing papers authored by Inger Helene Madshus

Since Specialization

Citations

This map shows the geographic impact of Inger Helene Madshus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inger Helene Madshus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inger Helene Madshus more than expected).

Fields of papers citing papers by Inger Helene Madshus

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inger Helene Madshus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inger Helene Madshus. The network helps show where Inger Helene Madshus may publish in the future.

Co-authorship network of co-authors of Inger Helene Madshus

This figure shows the co-authorship network connecting the top 25 collaborators of Inger Helene Madshus. A scholar is included among the top collaborators of Inger Helene Madshus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inger Helene Madshus. Inger Helene Madshus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bertelsen, Vibeke, et al.. (2013). Pertuzumab counteracts the inhibitory effect of ErbB2 on degradation of ErbB3. Carcinogenesis. 34(9). 2031–2038. 23 indexed citations

Breen, Kamilla, Sissel Beate Rønning, Nina Marie Pedersen, et al.. (2012). The oncoprotein ErbB3 is endocytosed in the absence of added ligand in a clathrin-dependent manner. Carcinogenesis. 33(5). 1031–1039. 24 indexed citations

Berger, Christian, Ute Krengel, Espen Stang, Ernesto Moreno, & Inger Helene Madshus. (2011). Nimotuzumab and Cetuximab Block Ligand-independent EGF Receptor Signaling Efficiently at Different Concentrations. Journal of Immunotherapy. 34(7). 550–555. 32 indexed citations

Pedersen, Nina Marie, et al.. (2009). Expression of Epidermal Growth Factor Receptor or ErbB3 Facilitates Geldanamycin-Induced Down-Regulation of ErbB2. Molecular Cancer Research. 7(2). 275–284. 16 indexed citations

Pedersen, Nina Marie, Inger Helene Madshus, Camilla Haslekås, & Espen Stang. (2008). Geldanamycin-Induced Down-Regulation of ErbB2 from the Plasma Membrane Is Clathrin Dependent but Proteasomal Activity Independent. Molecular Cancer Research. 6(3). 491–500. 46 indexed citations

Kazazić, Maja, Vibeke Bertelsen, Ketil Winther Pedersen, et al.. (2008). Epsin 1 is Involved in Recruitment of Ubiquitinated EGF Receptors into Clathrin‐Coated Pits. Traffic. 10(2). 235–245. 87 indexed citations

Grandal, Michael V. & Inger Helene Madshus. (2008). Epidermal growth factor receptor and cancer: control of oncogenic signalling by endocytosis. Journal of Cellular and Molecular Medicine. 12(5a). 1527–1534. 76 indexed citations

Kazazić, Maja, Kirstine Roepstorff, Lene E. Johannessen, et al.. (2006). EGF‐Induced Activation of the EGF Receptor Does Not Trigger Mobilization of Caveolae. Traffic. 7(11). 1518–1527. 57 indexed citations

Pedersen, Nina Marie, et al.. (2005). Herceptin‐induced inhibition of ErbB2 signaling involves reduced phosphorylation of Akt but not endocytic down‐regulation of ErbB2. International Journal of Cancer. 116(3). 359–367. 113 indexed citations

10.

Johannessen, Lene E., Nina Marie Pedersen, Ketil Winther Pedersen, Inger Helene Madshus, & Espen Stang. (2005). Activation of the Epidermal Growth Factor (EGF) Receptor Induces Formation of EGF Receptor- and Grb2-Containing Clathrin-Coated Pits. Molecular and Cellular Biology. 26(2). 389–401. 94 indexed citations

11.

Haslekås, Camilla, Kamilla Breen, Ketil Winther Pedersen, et al.. (2005). The Inhibitory Effect of ErbB2 on Epidermal Growth Factor-induced Formation of Clathrin-coated Pits Correlates with Retention of Epidermal Growth Factor Receptor-ErbB2 Oligomeric Complexes at the Plasma Membrane. Molecular Biology of the Cell. 16(12). 5832–5842. 81 indexed citations

12.

Grøvdal, Lene Melsæther, Espen Stang, Alexander Sorkin, & Inger Helene Madshus. (2004). Direct interaction of Cbl with pTyr 1045 of the EGF receptor (EGFR) is required to sort the EGFR to lysosomes for degradation. Experimental Cell Research. 300(2). 388–395. 141 indexed citations

13.

Stang, Espen, Maja Kazazić, Vibeke Bertelsen, et al.. (2004). Cbl-dependent Ubiquitination Is Required for Progression of EGF Receptors into Clathrin-coated Pits. Molecular Biology of the Cell. 15(8). 3591–3604. 133 indexed citations

14.

Johannessen, Lene E., et al.. (2001). Heterodimerization of the epidermal-growth-factor (EGF) receptor and ErbB2 and the affinity of EGF binding are regulated by different mechanisms. Biochemical Journal. 356(1). 87–87. 30 indexed citations

15.

Johannessen, Lene E., Tove Ringerike, Janne Molnes, & Inger Helene Madshus. (2000). Epidermal Growth Factor Receptor Efficiently Activates Mitogen-Activated Protein Kinase in HeLa Cells and Hep2 Cells Conditionally Defective in Clathrin-Dependent Endocytosis. Experimental Cell Research. 260(1). 136–145. 35 indexed citations

16.

Madshus, Inger Helene. (1995). Diphtheria toxin can be used as a vehicle for bringing other proteins into cells. Restorative Neurology and Neuroscience. 8(1-2). 13–14. 2 indexed citations

17.

Madshus, Inger Helene. (1994). The N-terminal alpha-helix of fragment B of diphtheria toxin promotes translocation of fragment A into the cytoplasm of eukaryotic cells. Journal of Biological Chemistry. 269(26). 17723–17729. 23 indexed citations

18.

Ariansen, Sarah, Boris N. Afanasiev, Jan Ø. Moskaug, et al.. (1993). Membrane translocation of diphtheria toxin A-fragment: role of carboxy-terminal region. Biochemistry. 32(1). 83–90. 24 indexed citations

19.

Madshus, Inger Helene & Harald Stenmark. (1992). Entry of ADP-Ribosylating Toxins into Cells. Current topics in microbiology and immunology. 175. 1–26. 24 indexed citations

20.

Więdłocha, Antoni, Inger Helene Madshus, H. Mach, C. Russell Middaugh, & Sjur Olsnes. (1992). Tight folding of acidic fibroblast growth factor prevents its translocation to the cytosol with diphtheria toxin as vector.. The EMBO Journal. 11(13). 4835–4842. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact